Prot #CBGJ398X2201: A Phase 2, Multicenter, Open-Label Study Of BGJ398 in Patients with Recurrent Resectable or Unresectable Glioblastoma

  • Raizer, Jeffrey J (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/12/13 → 4/1/18

Funding

  • Novartis Pharmaceuticals Corporation (Prot #CBGJ398X2201)